Showing 1,441 - 1,460 results of 100,180 for search '(( 5 mg decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.26s Refine Results
  1. 1441
  2. 1442
  3. 1443
  4. 1444
  5. 1445

    Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy<sup>2J</sup> Mouse Model of Congenital Muscular Dystrophy by Qing Yu (337275)

    Published 2013
    “…</p><p>Methods</p><p>dy<sup>2J</sup> mice were treated with vehicle, 0.1 mg/kg or 1 mg/kg of omigapil daily via oral gavage over 17.5 weeks. …”
  6. 1446

    The effect of TNFSF13 exposure on intracellular pH, and of decreased intracellular pH on TNFSF13 and FAS receptor gene expression. by Vibeke Sørensen Catts (168775)

    Published 2012
    “…<p>Intracellular pH of U-87 MG cells was artificially decreased using nigericin and phosphate buffer to pH 6.4, 6.9 and 7.3 for 0.5, 3, 12 or 24 hours and transcript levels of the TNFSF13 (A) or FAS receptor (B) genes measured by qRT-PCR. …”
  7. 1447
  8. 1448

    Administration of APB5, but not APA5, decreases the hyperplasia of alveolar type 2 epithelial cells induced by BLM. by Masami Kishi (6167105)

    Published 2018
    “…The administration of APB5 markedly decreased the hyperplasia of type 2 epithelial cells induced by BLM. …”
  9. 1449
  10. 1450
  11. 1451
  12. 1452
  13. 1453
  14. 1454

    Wounds treated with sDll4-Fc have increased vascular density but decreased vascular maturation in direct proportion to the dosage level. by Alexandre Trindade (187498)

    Published 2012
    “…C,D,E) Representative anti-PECAM and anti-SMA immunofluorescence images of neo-vasculature in granulation tissue of wounds treated with (D) 0,05 mg/kg or (E) 2,5 mg/kg compared with control mice injected with PBS (C), in days 2, 4 and 6. sDll4-Fc therapy leads to decreased smooth muscle cell recruitment and increased vascular density that is directly proportional to the administered dosage. * In graphics represents p<0,05.…”
  15. 1455
  16. 1456

    Attenuation of spheroid size decrease or MUC5AC increase by hit compounds. by Pranjali Beri (14945400)

    Published 2023
    “…<p>Final hit compounds (with hit concentration and corresponding target) that <b>A)</b> increased bronchosphere size compared to DMSO + 3% CSE control bronchospheres or <b>B)</b> decreased secreted MUC5AC. …”
  17. 1457
  18. 1458

    Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

    Published 2022
    “…<p><b>(</b>A and F) Representative immunoblots of hippocampal (A) and cortical (F) lysates of non-transgenic and 5XFAD mice treated with vehicle or nimodipine. …”
  19. 1459
  20. 1460